Patents by Inventor Robert G. Linde

Robert G. Linde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thrombopoietin Receptor Agonists
    Publication number: 20080076771
    Abstract: A compound of the formula (I) useful as promoters of thrombopoiesis and megakaryocytopoiesis, wherein A, B, D, E, W, X, Y, Z, R1 and R2 are defined as above.
    Type: Application
    Filed: September 12, 2005
    Publication date: March 27, 2008
    Inventors: Lawrence A. Reiter, Robert G. Linde
  • Hygromycin A derivatives
    Patent number: 6867230
    Abstract: This invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3 and R10 are as defined herein. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1, methods of treating bacterial and protozoal infections by administering the compounds of formula 1.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: March 15, 2005
    Assignee: Pfizer, Inc.
    Inventors: Matthew Merrill Hayward, Michael S. Visser, Robert G. Linde, II, Takushi Kaneko
  • Hygromycin derivatives
    Patent number: 6562792
    Abstract: The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X, Y, V, W1, W2, Z1 and Z2 are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods of treating bacterial and protozoal infections in mammals by administering the above compounds.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: May 13, 2003
    Assignee: Pfizer Inc.
    Inventors: Katherine E. Brighty, Robert G. Linde, Takushi Kaneko, Matthew M. Hayward
  • 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives
    Publication number: 20030055053
    Abstract: The present invention relates to compounds of the formula 1 1
    Type: Application
    Filed: June 5, 2002
    Publication date: March 20, 2003
    Inventors: Robert G. Linde, Matthew Merrill Hayward, Takushi Kaneko
  • Hygromycin a derivatives
    Publication number: 20030045528
    Abstract: This invention relates to compounds of the formula 1
    Type: Application
    Filed: June 1, 2001
    Publication date: March 6, 2003
    Inventors: Matthew Merrill Hayward, Michael S. Visser, Robert G. Linde, Takushi Kaneko
  • 4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives
    Publication number: 20020016297
    Abstract: The present invention relates to compounds of the formula 1 1
    Type: Application
    Filed: December 20, 2000
    Publication date: February 7, 2002
    Inventors: Robert G. Linde, Matthew Merrill Hayward, Takushi Kaneko
  • C-4 substituted macrolide antibiotics
    Patent number: 6300316
    Abstract: This invention relates to compounds of the formula and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: October 9, 2001
    Assignee: Pfizer Inc
    Inventors: Katherine E. Brighty, Takushi Kaneko, Robert G. Linde, II, Hiroko Masamune, Paul R. McGuirk, Wei-Guo Su, Yong-Jin Wu, Bingwei V. Yang